-
4841
Gingival and alveolar ridge overgrowths: A histopathological evaluation from Saudi Arabia
Published 2022-09-01“…The most common histologically diagnosed lesions were pyogenic granulomas (38%), fibromas (33%), peripheral ossifying fibromas (9%), squamous cell carcinomas (7%), peripheral giant cell granulomas (6%), neurofibromas (1%), and non-Hodgkin lymphomas (1%). Conclusion: Similar to what has been reported by most previous studies, reactive hyperplastic lesions were the most prevalent focal overgrowths found in the gingival and alveolar mucosae. …”
Get full text
Article -
4842
Modeling and affinity maturation of an anti-CD20 nanobody: a comprehensive in-silico investigation
Published 2023-01-01“…Abstract B-cell Non-Hodgkin lymphomas are the malignancies of lymphocytes. …”
Get full text
Article -
4843
Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma
Published 2020-08-01“…Background: Primary cutaneous B-cell lymphomas (pCBCL) include an infrequent group of non-Hodgkin lymphomas that are limited to skin sites at the time of diagnosis. …”
Get full text
Article -
4844
Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion.
Published 2003“…Survival from HIV seroconversion shows that compared with AIDS-free subjects, the risk of death associated with TB as an initial ADC (hazard ratio [HR] = 23.23, 95% CI: 14.60-36.96) does not differ from that associated with Kaposi sarcoma (HR = 23.47, 95% CI: 16.66-33.05) or esophageal candidiasis (OC)/Pneumocystis carinii pneumonia (PCP) (HR = 30.97, 95% CI: 24.38-39.34) but is lower than that for opportunistic infections other than TB, OC/PCP (HR = 46.83, 95% CI: 37.86-47.94) and high-grade non-Hodgkin lymphomas/invasive cervical carcinoma (HR = 92.71, 95% CI: 60.83-141.3). …”
Journal article -
4845
Expression of Apoptosis Related and Proliferative Proteins in Malignant Lympho-Proliferative Disorders
Published 2017-07-01“…The expression of P53 and PCNA in 35 biopsies of Non Hodgkin Lymphomas (NHL) was found to increase from low to high grade tumors. …”
Get full text
Article -
4846
Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma
Published 2020-07-01“…Abstract Background Diffuse large B-cell lymphoma (DLBCL) is a spectrum of disease comprising more than 30% of non-Hodgkin lymphomas. Although studies have identified several molecular subgroups, the heterogeneous genetic background of DLBCL remains ambiguous. …”
Get full text
Article -
4847
CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
Published 2021-05-01“…Primary CNS lymphomas (PCNSL) represent a group of extranodal non-Hodgkin lymphomas and secondary CNS lymphomas refer to secondary involvement of the neuroaxis by systemic disease. …”
Get full text
Article -
4848
GM-CSF enhanced the effect of CHOP and R-CHOP on inhibiting diffuse large B-cell lymphoma progression via influencing the macrophage polarization
Published 2021-03-01“…Abstract Background Diffuse large B-cell lymphoma (DLBCL) is a common type of the Non-Hodgkin lymphomas (NHLs) formed by the neoplastic transformation of mature B cells. …”
Get full text
Article -
4849
Hepatosplenic Gamma Delta T-Cell Lymphoma (HSGDTCL): Two Rare Case Reports from Western India
Published 2017-10-01“…Peripheral T cell lymphomas are a heterogeneous group of post-thymic, mature lymphoid malignancies, accounting for approximately 10-15% of all non-Hodgkin's lymphomas. Hepatosplenic T-cell lymphoma (HSGDTCL) is a rare entity, which is characterized by primary extra nodal disease with typical sinusoidal or sinusal infiltration of the liver and the spleen, respectively by expression of the T cell receptor chain, and by a number of other frequent clinicopathologic features, including aggressive course of disease. …”
Get full text
Article -
4850
Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years
Published 2022-07-01“…The most common cancers were breast (<i>n</i> = 34), lung (<i>n</i> = 24), colon–rectum–anus (<i>n</i> = 20), and non-Hodgkin lymphomas (NHL) (<i>n</i> = 20). Overall, no excess cancer risk was noted (SIR = 0.87), whereas the number of observed NHL cases was more than two-fold significantly higher than expected (SIR = 2.52). …”
Get full text
Article -
4851
Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature
Published 2023-05-01“…Here, we exploited bioinformatic tools, TCGA data, and tumor tissue samples from patients with diffuse large B-cell lymphoma (DLBCL), one of the most frequent non-Hodgkin lymphomas of B-cell origin, to investigate the distribution of the different immune cell subpopulations in DLBCL samples in order to characterize the immune landscape of their microenvironment. …”
Get full text
Article -
4852
Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas
Published 2021-05-01“…Peripheral T-cell lymphomas (PTCL) comprise a heterogeneous group of aggressive lymphoproliferative malignancies that account for approximately 10% of adult non-Hodgkins lymphomas. Despite the variety of PTCL subtypes, CHOP-like regimens are the standard first-line therapy in most cases. …”
Get full text
Article -
4853
An unusual presentation of gastric mucosa-associated lymphoid tissue (MALT)-type lymphoma
Published 2016-09-01“…Mucosa-associated lymphoid tissue (MALT)-type lymphoma is a relatively rare disease; nevertheless, it is the third most common lymphoma type, accounting for 5–7% of all non-Hodgkin lymphomas. Case series and retrospective analysis published in the literature have suggested that extra gastrointestinal (GI) MALT-type lymphoma can occur simultaneously with MALT-type lymphoma involving the GI tract. …”
Get full text
Article -
4854
Clinicopathological profile of Waldenström's macroglobulinemia: Experience from a tertiary care center
Published 2020-01-01“…It accounts for approx 2% of Non Hodgkin Lymphomas. The disease is slightly more common in elderly males, the median age at diagnosis being 63 years. …”
Get full text
Article -
4855
Patients with indolent lymphomas are at high risk of infections: experience from a German outpatient clinic
Published 2023-01-01“…Abstract Background Patients with indolent B-cell non-Hodgkin lymphomas (B-NHLs) have an increased risk of infections which is caused by pathomechanisms of the diseases itself but also as a result of anti-tumor therapy. …”
Get full text
Article -
4856
RIPK1 is aberrantly expressed in multiple B-cell cancers and implicated in the underlying pathogenesis
Published 2023-07-01“…Abstract According to the latest epidemiology of the US, B-cell cancers account for > 3% of all new cancer cases and > 80% of non-Hodgkin lymphomas. However, the disease-modifying small molecular drug suitable for most B-cell cancers is still lacking. …”
Get full text
Article -
4857
T-Cell Project: an international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma Projeto de célula-T: estudo internacional, longitudinal d...
Published 2009-08-01“…PTCLs express even more clinical diversity than B-cell non-Hodgkin's lymphomas, and there is a close, though not absolute, relationship between some unusual clinical features and certain histological subtypes.…”
Get full text
Article -
4858
Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas
Published 2022-10-01“…Primary cutaneous lymphomas comprise a heterogeneous group of extranodal non-Hodgkin lymphomas (NHL) that arise from skin resident lymphoid cells and are manifested by specific lymphomatous cutaneous lesions with no evidence of extracutaneous disease at the time of diagnosis. …”
Get full text
Article -
4859
Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of TRAF1-ALK-Associated Anaplastic Large Cell Lymphoma
Published 2020-05-01“…Background: Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is a rare T-cell neoplasm, accounting for approximately 3% of adult non-Hodgkin lymphomas. Although NPM1 is the most common fusion partner with ALK, many others have been described, necessitating break-apart FISH studies for confirmation of the diagnosis. …”
Get full text
Article -
4860
Primary Nodal Unclassifiable CD20 Negative Diffuse Large B-cell Lymphoma With Dual and Gene Rearrangement: A Diagnostic Challenge
Published 2023-01-01“…Non-Hodgkin lymphomas are most frequently classified based on the lineage marker expression. …”
Get full text
Article